Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection.

Xiao-Hui WangZi-Li HuYi-Zhen FuJing-Yu HouWen-Xuan LiYao-Jun ZhangLi XuQun-Fang ZhouMin-Shan ChenZhong-Guo Zhou

Published in: Journal of gastroenterology (2022)

For patients who underwent curative resection for HBV-related HCC, TDF treatment had a significantly better overall survival and better protection of liver function, but no difference in the incidences of HCC recurrence than ETV treatment.

Keyphrases

newly diagnosed
hepatitis b virus
liver failure
acute lymphoblastic leukemia
rectal cancer
prognostic factors
chronic kidney disease
end stage renal disease
free survival
combination therapy